(via NewsDirect)
Koetsier said of the company's latest figures, “Cann Group has made considerable progress over the course of the 2023 financial year. Most notably, the completion of construction on the Company’s flagship Mildura facility has now allowed Cann to truly pursue its goal of becoming Australia’s premier B2B medicinal cannabis supplier. This state-of-the-art facility represents a substantial investment and an asset that must be fully utilised to capitalise on its capabilities and production efficiencies. As we continue our growth towards Mildura’s 12.5-tonne, optimal capacity, we expect Cann to prove to be a globally competitive and profitable business.”
“The Company is now focused on scaling production of its high-quality portfolio, as well as fully resourcing our sales and marketing in an effort to quickly build revenue.”
Contact Details
+61 413 713 744
jonathan@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.
Copyright (c) 2023 TheNewswire - All rights reserved., source